KLAS Contact
Contact KLAS
Contact KLAS
2024 BEST IN KLAS
Preferences
Related Series
2021
2019
Related Segments
Patient Engagement Ecosystem 2023
An Update on Vendor-Reported Capabilities
Author
Adam Cherrington
Author
Dan Czech
Amid the pressures of today’s economic environment, healthcare organizations are investing heavily in patient engagement technology to help reduce costs, alleviate staffing challenges, and consolidate technology in other areas. Both provider and payer organizations seek to understand what patient engagement capabilities vendors offer that can meet their core needs. This study (along with additional deep-dive content that will be published on KLAS’ website) is an update to KLAS’ 2021 report and shows which vendors report the broadest capability sets, which vendors have made the most progress over the last two years, and how the industry as a whole has matured. For reader ease, links to relevant online content are provided where applicable. Note that the data in this study is based primarily on vendor-reported information, accompanied by a limited amount of KLAS performance data.
If you don't have a login, getting started is easy.
Key Findings:
- eVideon, pCare, RevSpring, Upfront, and Health Catalyst Report Largest Growth in Capabilities since 2021
- Epic Continues to Lead in Capability Breadth among Health System–Focused Vendors; Salesforce and Get Well Also Offer Broad Solutions
- athenahealth Again One of the Broadest Ambulatory-Focused Vendors; Newly Measured Rhinogram and HealthTalk A.I. Also Report Broad Capabilities
Writer
Sarah Brown
Designer
Bronson Allgood
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.